that ER-ȋ does not compensate for incompetent ER-Ȋ in this response. However, a proliferation response to strain was conferred on ERȊǁ/ǁ cells by transfecting them with a functional human wild-type ER-Ȋ expression vector (pRST7-ER;ref.8) (Fig. 1d).These results obtained in vivo and in vitro indicate that strain-related responses by differentiated cells of the osteoblast lineage require ER-Ȋ activity. This might explain why postmenopausal women no longer maintain adequate bone mass -their bone cells are less responsive to mechanical stimulation owing to decreased ER-Ȋ activity.The oestrogen receptor is the ancestral steroid receptor 9 , with one of its possible early reproductive functions being to induce brief communications
Osteoblast-like cells in primary cultures derived from ER␣؊/؊ mice do not proliferate in response to mechanical strain, unlike those from their ER␣ ؉/؉ littermates. ER␣ ؊/؊ cells also lack strainrelated NO production and responsiveness to IGFs. Proliferative responsiveness to strain is rescued by transfection with functional ER␣. ER␣ number or function in bone cells may limit bones' adaptability to mechanical loading.Introduction: In vivo, bones' osteogenic response to mechanical loading involves proliferation of surface osteoblasts. This response is replicated in vitro and involves ERK-mediated activation of the estrogen receptor (ER) ␣ and upregulation of estrogen response element activity. This proliferative response can be blocked by selective estrogen receptor modulators and increased by transfection of additional ER␣.
Materials and Methods:We have now investigated the mechanisms of ER involvement in osteoblast-like cells' early responses to strain by comparing the responses of primary cultures of these cells derived from homozygous ER␣ knockout (ERKO) mice (ER␣
Objectives The aim of this study was to compare indications, complications and mortality rates for perineal urethrostomy (PU), transpelvic urethrostomy (TPU) and prepubic urethrostomy (PPU). Methods A retrospective review of, and follow-up owner questionnaire for, cats undergoing urethrostomy between 2008 and 2018, at a single referral hospital, were performed. Results Fifty-six cats underwent urethrostomy (PU, n = 37; TPU, n = 8; PPU, n = 11). The presenting problem was significantly associated with urethrostomy technique ( P <0.001). For PU cats, feline idiopathic cystitis (FIC; n = 21 [56.7%]) was the most common problem, whereas for PPU cats, trauma (n = 9 [81.8%]) was most common ( P <0.001). Urethrostomy technique was associated with imaging diagnosis ( P <0.001) of the urethral lesion. Most PU cats had no diagnostic imaging lesion (n = 15 [40.5%]) or obstructive calculi or clots (n = 10 [27.0%]), and all PPU cats had urethral rupture. Ten (90.9%) PPU cats had a pelvic lesion, while 21 (56.7%) PU cats had a penile lesion. TPU cats had a range of presenting problems and imaging diagnoses. Short- and long-term complications were reported in 33/55 (60.0%) and 11/30 (36.7%) cats, respectively. The number of cats with long-term complications was greater among PPU cats ( P = 0.02). Short-term dermatitis ( P = 0.019) and long-term incontinence ( P = 0.01) were associated with PPU. Short-term mortality was 5.6% and long-term mortality was 13.3%; both were independent of urethrostomy technique. Quality of life post-urethrostomy, across all techniques, was graded as good by 93% of owners. Conclusions and relevance In this study, PU was the most common feline urethrostomy technique indicated for FIC. Short-term urethrostomy complications are common, irrespective of urethrostomy technique. Long-term complications are less frequent but more common with PPU.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.